Nektar Therapeutics
NKTR
NKTR
137 hedge funds and large institutions have $183M invested in Nektar Therapeutics in 2024 Q3 according to their latest regulatory filings, with 22 funds opening new positions, 37 increasing their positions, 34 reducing their positions, and 17 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
137
Holders Change
+5
Holders Change %
+3.79%
% of All Funds
1.98%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
22
Increased
37
Reduced
34
Closed
17
Calls
$182K
Puts
$23K
Net Calls
+$159K
Net Calls Change
+$186K
Top Buyers
| 1 |
EAM
Eventide Asset Management
Boston,
Massachusetts
|
$12.2M |
| 2 |
BCM
Bridgeway Capital Management
Houston,
Texas
|
$1.77M |
| 3 |
WP
Woodline Partners
San Francisco,
California
|
$2.25M |
| 4 |
Northern Trust
Chicago,
Illinois
|
$1.82M |
| 5 |
BlackRock
New York
|
$20.8M |
Top Sellers
| 1 |
DTC
Deep Track Capital
Greenwich,
Connecticut
|
$20.7M |
| 2 |
Morgan Stanley
New York
|
$970K |
| 3 |
GCP
GSA Capital Partners
London,
United Kingdom
|
$279K |
| 4 |
Two Sigma Investments
New York
|
$1.77M |
| 5 |
Two Sigma Advisers
New York
|
$1.95M |